ADVERTISEMENT
News
Diluent Recalled
11/25/2020
Hikma Pharmaceuticals voluntarily initiated the recalls on November 3, 2020. On November 20, 2020, the FDA designated them Class II, signaling use of the product could cause temporary or medically reversible adverse health consequences. A remote possibility of serious harm also exists.
Sodium chloride injection is used for diluting or dissolving drugs for intravenous, intramuscular, or subcutaneous injection.
—Jolynn Tumolo